Registration
 
All news
Top Stories
Editors' Picks
Stocks
Crypto
Financial News
Currencies
Commodities
Companies
Central Banks
Ashutosh Sureka
Ashutosh Sureka

Merck announces Phase 3 trial results for new HIV treatment at CROI2026

Merck announces Phase 3 trial results for new HIV treatment at CROI2026
Merck reveals HIV trial results

Merck has unveiled new results from three Phase 3 clinical trials evaluating its investigational HIV treatment during the CROI2026 conference.

The trials reflect ongoing research efforts to address HIV with novel therapies. Merck has invited stakeholders and the medical community to learn more through additional resources available online.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Editor's Picks for You

Bitcoin price prediction and Bollinger Bands: Can BTC recover after falling to $63,000?
  • By Mikhail Vnuchkov
  • 14 hours ago
Bitcoin price prediction and Bollinger Bands: Can BTC recover after falling to $63,000?
Editors' Picks
FIFA World Cup on blockchain: Where football meets crypto
  • By Oleg Tkachenko
  • Yesterday
FIFA World Cup on blockchain: Where football meets crypto
Editors' Picks
Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged
  • By Pavlo Kot
  • 21.06.2026
Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged
Editors' Picks
All Editors' Top Picks

Latest Merck News

Merck stock slides amid strong selling pressure despite Phase 3 immunology trial update
  • By Jose Antonio Gastelum
  • Yesterday
Merck stock slides amid strong selling pressure despite Phase 3 immunology trial update
Companies
#Merck
Merck stock drops 1.25% as company posts strong Phase 3 HIV data with Gilead Sciences
  • By Ezequiel Gomes
  • 09.06.2026
Merck stock drops 1.25% as company posts strong Phase 3 HIV data with Gilead Sciences
Companies
#Merck
Merck stock price forecast: bullish bias and tight range as MRK holds near highs
  • By Jose Antonio Gastelum
  • 13.04.2026
Merck stock price forecast: bullish bias and tight range as MRK holds near highs
Companies
#Merck
All Merck News
  • Mikhail Vnuchkov
  • 14 hours ago
Bitcoin price prediction and Bollinger Bands: Can BTC recover after falling to $63,000?
  • Oleg Tkachenko
  • Yesterday
FIFA World Cup on blockchain: Where football meets crypto
  • Pavlo Kot
  • 21.06.2026
Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged
  • Pavlo Kot
  • 20.06.2026
Blockchain nation in crisis: How a power struggle split Liberland
  • Eugene Komchuk
  • 19.06.2026
Shifting priorities: Governments back mining as businesses turn to AI
  • Artem Shendetskii
  • 1 hour ago
Howard Lindzon: Financial markets experience SaasPocalypse as CFTC-backed perps disrupt exchanges
  • Elena Nikulina
  • 1 hour ago
Ryan Detrick: S&P 500 has never peaked in June, current trend not expected to break record
  • Yaroslav Dmytrenko
  • 1 hour ago
Crypto sector experiences waves of innovation, John Walsh notes
  • Hanna Syniavska
  • 1 hour ago
Arthur Hayes: CARDS token has strong investment thesis and momentum
  • Mikhail Vnuchkov
  • 1 hour ago
Scott Lincicome: Contrasts between IRA types and Trump Accounts taxation
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.
Top News
  • Olga Shendetskaya
  • 9 hours ago
Digital euro gains momentum as Europe seeks payment independence
Digital euro gains momentum as Europe seeks payment independence
  • Hanna Syniavska
  • 11 hours ago
Oracle workforce shrinks 13% over past year as AI push accelerates
Oracle workforce shrinks 13% over past year as AI push accelerates
  • Andrey Mastykin
  • 13 hours ago
U.S. stock futures fall as investors pull back from tech shares
U.S. stock futures fall as investors pull back from tech shares
  • Igor Krasulya
  • 14 hours ago
Meta takes minority stake in Indian fintech Cred
Meta takes minority stake in Indian fintech Cred
  • Olga Shendetskaya
  • 15 hours ago
Oil market slips despite lingering risks around Iran deal
Oil market slips despite lingering risks around Iran deal
Live News
  • Anton Kharitonov
  • Now
Goog;e pulls back as AI talent concerns pressure sentiment
  • Anton Kharitonov
  • Now
Apple pulls back below $300 as AI doubts offset strong fundamentals
  • Mykhailo Ihnatenko
  • Now
Tesla struggles below key resistance amid market uncertainty
  • Mykhailo Ihnatenko
  • Now
AMD faces rising correction risks despite AI sector optimism
  • Anton Kharitonov
  • Now
Bitcoin holds near $62,000 as weak risk appetite weighs
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org World Association of News Publishers https://gdpr.eu/ GDPR